Skip to main content

Company News

April 15, 2024

bioMérieux Named Business of the Year by Utah Governor’s Office of Economic Opportunity

bioMérieux, a world leader in the field of in vitro diagnostics, has received the 2024 Business of the Year Award, presented by the Utah Governor’s Office of Economic Opportunity at One Utah Summit April 11-12, in Salt Lake City.
Discover More

  • March 08, 2023

    March 8 – and every day –, let’s #EmbraceEquity

    At bioMérieux, we support the inclusion, well-being and development of our team members and are committed to creating a culture of belonging and acceptance where all feel respected, supported and included.
    Read more

  • February 27, 2023

    2022: a fruitful year of CSR achievements

    We are committed to play our part and as every gesture counts to change the game, we have implemented a number of concrete actions in line with our CSR objectives.
    Read more

  • February 21, 2023

    bioMérieux launches a PCR kit for detection of the monkeypox virus

    bioMérieux has developed a MONKEYPOX R-GENE® PCR kit. Available for research use only (RUO), this kit can easily be used by laboratories around the world.
    Read more

  • January 18, 2023

    bioMérieux and InDevR partnership

    bioMérieux is making a $5 million investment in InDevR, and will be the exclusive distributor in Europe of VaxArray®, a state-of-the-art vaccine quality control platform developed by the American company.
    Read more

Follow us on Socials for more news!